Actively Recruiting

Phase Not Applicable
Age: 19Years +
All Genders
NCT06897501

Postoperative Vocal Cord Palsy Between Double-lumen Endobronchial Tube and Bronchial Blocker for Robot-assisted Esophagectomy

Led by Samsung Medical Center · Updated on 2025-05-18

202

Participants Needed

1

Research Sites

85 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to investigate whether the use of bronchial blocker could reduce the incidence of postoperative vocal cord palsy than the use of double-lumen endobronchial tube in robot-assisted esophagectomy.

CONDITIONS

Official Title

Postoperative Vocal Cord Palsy Between Double-lumen Endobronchial Tube and Bronchial Blocker for Robot-assisted Esophagectomy

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 19 or older
  • American Society of Anesthesiologists physical status I - III
  • Elective robot-assisted esophagectomy
  • Any clinical stage of esophageal cancer
  • Patients who need recurrent laryngeal nerve lymph nodes resection
Not Eligible

You will not qualify if you...

  • Patients diagnosed with vocal cord palsy or damage before surgery
  • Patients who need specific airway device due to airway problem
  • History of thoracic surgery
  • Emergency surgery
  • Combined surgery with other department
  • Pregnant or nursing women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Samsung Medical Center

Seoul, South Korea, 06351

Actively Recruiting

Loading map...

Research Team

H

Hyun Joo Ahn, MD PhD

CONTACT

H

Heejoon Jeong, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here